\centered **AMENDMENT NO. 2 TO REGISTRATION RIGHTS AGREEMENT** 

This Amendment No. 2 (the “**Amendment No. 2**”) is made as of [[Date 1: Date]] to that certain Registration Rights Agreement (the “**Agreement**”) dated as of [[Date 2: Date]], as amended by Amendment No. 1 thereto dated as of [[Date 3: Date]], between eDiets.com, Inc., a [[State of Formation: State]] [[Organization: EntityType]] (the “**Company**”), the Investors named therein and [[Organization 1 Name]] I, L.P. (“**Prides**”). Capitalized terms not otherwise defined in this Amendment No. 2 have the meanings provided in the Agreement. 

NOW, THEREFORE, the parties hereto agree as follows: 

^The Recitals to the Agreement are hereby amended and restated in full to read as follows: 

“A. The Company sold and issued to the Investors an aggregate of [[Shares 1: Number]] shares of the Company’s common stock and warrants to purchase up to [[Shares 2: Number]] shares of the Company’s common stock in private placements for an aggregate purchase price of $[[USD Value 1: Number]] under the terms and subject to the conditions of those certain Securities Subscription and Purchase Agreements dated as of [[Date 2]] and [[Date 3]] (each a “**Purchase Agreement**” and together the “**2009 Purchase Agreements**”). 

^The Company and Prides entered into an Agreement to Amend Warrants dated [[Date 2]] (the “**Amendment**”) pursuant to which the Company reduced the exercise price of certain outstanding warrants issued to Prides (the “**Existing Prides Warrants**”) in consideration of the agreement by Prides to use diligent efforts to exercise, in one or more tranches, a portion of the Existing Prides Warrants as soon as reasonably practicable in order to purchase [[Shares 3: Number]] shares of the Company’s common stock. 

^The Amendment further provided that, upon each such exercise of the Existing Prides Warrants, the Company will issue to Prides a warrant (each a “**New Prides Warrant**”) to purchase up to a number of shares of the Company’s common stock equal to [[Percentage 1: Number]]% of the shares of the Company’s common stock issued as a result of such exercise (the “**Prides Warrant Shares**”). 

^The Company has sold and issued to the Investors an additional [[Shares 4: Number]] shares of the Company’s common stock in private placements for an aggregate purchase price of $[[USD Value 2: Number]] under the terms and subject to the conditions of Securities Subscription and Purchase Agreements dated as of [[Date 1]] (the “**[[Date 4: Date]] Purchase Agreement**s”) 

^The Company has issued to Prides pursuant to a Debt Conversion Agreement, dated as of [[Date 1]], by and between the Company and Prides (the “**Prides Debt Conversion Agreement**”) an aggregate number of shares of the Company’s common stock as set forth in Exhibit A hereto under the column “Shares Acquired under 2010 Private Placement Documents.” 

^The Company has issued to [[Person 1 First Name]] [[Person 1 Last Name]], II (“**Richardson**”) pursuant to a Debt Conversion Agreement, dated as of [[Date 1]], by and between the Company and Richardson an aggregate number of shares of the Company’s common stock as set forth in Exhibit A hereto under the column “Shares Acquired under 2010 Private Placement Documents.” (the “**Richardson Debt Conversion Agreement**” and collectively with the [[Date 4]] Purchase Agreements and the Prides Debt Conversion Agreement, the “**2010 Private Placement Documents**”). 

^The Company has agreed to register (i) the shares of the Company’s common stock issued pursuant to the 2009 Purchase Agreements and the 2010 Private Placement Documents (collectively the “**Investor Shares**”) and (ii) the shares of the Company’s common stock issued or issuable upon exercise of the warrants to purchase common stock issued pursuant to the 2009 Purchase Agreements (such warrants, the “**Investor Warrants**” and, together with the New Prides Warrants, the “**Warrants**”; and the shares issued or issuable upon exercise of the Investor Warrants, together with the Prides Warrant Shares, the “**Warrant Shares**”), all of which Investor Shares and Warrant Shares are set forth on Exhibit A attached hereto.” 

^The following clause shall be added to the end of Section 3(d)(i) of the Agreement: 

“; provided, that the foregoing proviso shall not apply to the extent that the Selling Shareholder has furnished in writing to the Company prior to the filing of any such Registration Statement, amendment thereof, free writing prospectus, preliminary prospectus, prospectus, amendment or supplement information expressly for use in such Registration Statement, amendment thereof, free writing prospectus, preliminary prospectus, prospectus, amendment or supplement which corrected or made not misleading information previously furnished to the Company, and the Company failed to include such information therein.” 

^The following clause shall be added to the end of Section 3(d)(ii) of the Agreement: 

“; provided, that such Selling Shareholder shall not be liable under clause (ii) in any such case to the extent that the Selling Shareholder has furnished in writing to the Company prior to the filing of any such Registration Statement, free writing prospectus, preliminary prospectus, prospectus or amendment or supplement information expressly for use in such Registration Statement, preliminary prospectus, prospectus or amendment or supplement which corrected or made mot misleading information previously furnished to the Company, and the Company failed to include such information therein.” 

^The phrase “this Section 4” in Section 4 of the Agreement shall be deleted and replaced with the phrase “Section 2”. 

^Section 7 of the Agreement shall be amended and restated to read as follows: 

“7. [Intentionally omitted.]” 

^Exhibit A to the Agreement is hereby deleted and replaced in its entirety with Exhibit A attached hereto. 

^In all other respects the Agreement shall remain unaltered and continue in full force and effect and nothing herein shall be construed as a waiver or modification of existing rights under the Agreement, except as such rights are expressly modified by this Amendment No. 2. This Amendment No. 2 and the Agreement, as amended to the date hereof, shall be read and construed as one document. 

^This Amendment No. 2 may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same document. 

^This Amendment No. 2 shall not become effective unless and until closing under the Prides Debt Conversion Agreement occurs, whereupon this Amendment No. 2 shall become effective without need for further action, agreement or documentation on the part of any party. This Amendment No. 2 shall automatically terminate in the event that the Prides Debt Conversion Agreement terminates. 

\centered *[Remainder of Page Intentionally Left Blank.]* 

Please confirm that the foregoing correctly sets forth the agreement among us by signing below. 

[[Organization 1 Name]] I, L.P.  By: [[Organization 2 Name]], its General Partner            EDIETS.COM, INC.

[[[[Organization 1 Name]] I L.P.  By [[Organization 2 Name]] its General Partner            EDIETS.COM INC. Signatory Email: Identity | Signature]]
__________________________________________
{{[[Organization 1 Name]] I L.P.  By [[Organization 2 Name]] its General Partner            EDIETS.COM INC. Entity => By: [[[[Organization 1 Name]] I L.P.  By [[Organization 2 Name]] its General Partner            EDIETS.COM INC. Signatory First Name]] [[[[Organization 1 Name]] I L.P.  By [[Organization 2 Name]] its General Partner            EDIETS.COM INC. Signatory Last Name]]
Title: [[[[Organization 1 Name]] I L.P.  By [[Organization 2 Name]] its General Partner            EDIETS.COM INC. Signatory Title]]}}


INVESTORS:

[[Person 2 First Name]] [[Person 2 Last Name]]

/s/ [[Person 2 First Name]] [[Person 2 Last Name]]

[[Person 3 First Name]] [[Person 3 Last Name]]

/s/ [[Person 3 First Name]] [[Person 3 Last Name]]

[[Person 1 First Name]] [[Person 1 Last Name]] II

/s/ [[Person 1 First Name]] [[Person 1 Last Name]], II

\centered *[SIGNATURE PAGE TO AMENDMENT NO. 2 TO REGISTRATION RIGHTS AGREEMENT]* 

**EXHIBIT A** 

**Investor Name & Address**      **Shares Purchased under 2009 Purchase Agreements or through Exercise of Existing Prides Warrants**      **Warrant Shares (New Prides Warrants and Warrants Issued under 2009 Purchase Agreements)**      **Shares Acquired under 2010 Private Placement Documents**

[[Person 2 First Name]] [[Person 2 Last Name]]  One Cedar Lane  Woodside, CA 94062      194,340      87,453      100,000

[[Person 3 First Name]] [[Person 3 Last Name]]  Del Charter Gtee & Tst Co TTEE  FBO [[Person 4 First Name]] [[Person 4 Last Name]] IRA  Account # 003 283 256  [[Organization 3 Name]]  Attn: Transfer of Assets Team  295 Chipeta Way, 4th Floor  [[Address 1: Address]]-1220      571,700      257,265      [[Shares 5: Number]]

[[Person 1 First Name]] [[Person 1 Last Name]] II  c/o [[Organization 4 Name]]  200 State Street  13th Floor  [[Address 2: Address]]      300,000      135,000      **

[[Organization 1 Name]] I, L.P.  c/o [[Organization 4 Name]]  200 State Street  13th Floor  [[Address 2: Address]]      2,688,119      1,209,652      ***

**   200,000 shares of common stock purchased pursuant to the [[Date 4]] Purchase Agreements, plus an amount of shares to be issued pursuant to the Richardson Debt Conversion Agreement equal to [[Shares 6: Number]] shares of common stock plus an additional number of shares equal to the product (rounded down to the nearest whole number) of (i) 68 multiplied by (ii) the number of days that have elapsed from [[Date 5: Date]] to the closing of the Richardson Debt Conversion Agreement.

***   An amount of shares equal to [[Shares 7: Number]] shares of common stock plus an additional number of shares to be issued pursuant to the Prides Debt Conversion Agreement equal to the product (rounded down to the nearest whole number) of (i) 9,321 multiplied by (ii) the number of days that have elapsed from [[Date 5]] to the closing of the Prides Debt Conversion Agreement.